科研之友
微信
新浪微博
Facebook
分享链接
摘要
In this issue of Blood Bouska et al give an excellent example of an integrated molecular approach applied to high-grade B-cell lymphoma with the molecular Burkitt lymphoma (BL) signature.(1) This study has several practical implications regarding (1) the concept of the pathological entity (2) the understanding of the different mechanisms at work in patients who apparently have the same disease and (3) the impact that a comprehensive molecular approach can have on the identification of novel therapeutic targets.
- 出版日期2017-10-19
